Table 3.
Source | Compound | Cell Type | Hormone | Dose Response |
---|---|---|---|---|
Synthetic compounds 0, 0.00001, 0.0001, 0.001, 0.01, 0.1 mg/mL | 6,6′ dibromoindirubin | JAr | Basal P4 | N-shaped 1, low doses stimulated, 0 and high doses N/E, 4 h, 6 h, 8 h, 10 h |
indirubin | Basal P4 | N-shaped, Low doses stimulated, 0 and high doses N/E, 24 h | ||
5-bromoisatin | Basal P4 | N-shaped, low doses stimulated, 0 and high doses N/E, 24 h | ||
indirubin | GC | Basal P4 | U-shaped 2, 48 h, 72 h | |
5-bromoisatin | Basal P4 | Dose-dependent stimulation, 48 h | ||
Hypobranchial gland extract 0, 0.005, 0.01, 0.05, 0.1, 0.5, 1 mg/mL | mixture of 6-bromoisatin, tyrindolinone, tyrindoleninone, tyrindoxyl sulphate | GC | Basal P4 | N/E |
hCG P4 | N/E | |||
Basal E2 | 0.05 mg/mL stimulated, 24 h | |||
hCG E2 | U-shaped, 4 h, 24 h, 48 h | |||
tyrindoleninone | GC | Basal P4 | N/E | |
hCG P4 | N/E | |||
Basal E2 | N-shaped, 24, 48 h | |||
hCG E2 | N-shaped, 24, inhibition—48 h | |||
6-bromoisatin | GC | Basal P4 | U-shaped 4 h, N/E 24 h, 48 h | |
hCG P4 | N/E | |||
Basal E2 | U-shaped 4 h, N/E 24 h, 48 h | |||
hCG E2 | Dose-dependent inhibition 4 h, 48 h | |||
Egg mass extract 0, 0.005, 0.05, 0.5 mg/mL | mixture of 6-bromoisatin, tyrindolinone, tyrindoleninone, tyriverdin | GC | Basal P4 | N/E |
hCG P4 | Dose-dependent stimulation, 48 h | |||
Basal E2 | N/E | |||
hCG E2 | Dose-dependent stimulation, 48 h | |||
tyrindoleninone | GC | Basal P4 | N/E | |
hCG P4 | Dose-dependent inhibition | |||
Basal E2 | N-shaped 24, 48 h | |||
hCG E2 | Stimulation 4, 24 h, n-shaped 48 h | |||
Egg mass extract 0, 0.005, 0.05, 0.5 mg/mL | 6-bromoisatin | GC | Basal P4 | Lowest dose cytotoxic |
hCG P4 | Dose-dependent inhibition, 48 h | |||
Basal E2 | Lowest dose cytotoxic | |||
hCG E2 | Dose-dependent stimulation, 48 h |
JAr—human chorioplacental cancer cell line, GC—human primary-derived granulosa cells, P4—progesterone, E2—estradiol 17 beta, basal—constitutive hormone synthesis, hCG—exposed to human chorionic gonadotrophin in vitro, N/E—no effect and the same as control, stimulation—steroid hormone synthesis stimulated to be significantly higher than controls, inhibition—steroid hormone synthesis significantly lower than controls, h—hours of exposure in vitro [106,136].1 N shaped curve = typical hormetic response with low dose stimulation and high dose inhibition; 2 U shaped response = inverse hormesis with low dose inhibition and high dose stimulation.